Global Drug-Eluting Coating Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

Global Drug-Eluting Coating Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

  • SKU :
    SAC7208855
  • Published Date :
    May 31, 2024
  • Number of Pages :
    300

Product Description

The Drug-Eluting Coating market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031.

Considering the influence of COVID-19 on the global Drug-Eluting Coating market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Drug-Eluting Coating Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Drug-Eluting Coating market are:
Hemoteq AG (Germany)
N2 Biomedical (US)
Carmeda AB (Sweden)
Covalon Technologies Ltd. (Canada)
AST Products, Inc. (US)
Nanocopoeia, Inc. (US)
Armoloy of Connecticut, Inc. (US)
Biophan Technologies, Inc. (US)
Hydromer, Inc. (US)
Biocoat, Inc. (US)

Most important types of Drug-Eluting Coating products covered in this report are:
Biocompatible coatings
Drug-delivery coatings
Polymer-free coatings/surfaces

Most widely used downstream fields of Drug-Eluting Coating market covered in this report are:
Hospital
Research institute

Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.





Table of Content

Table of Content

1 Drug-Eluting Coating Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Drug-Eluting Coating
1.3 Drug-Eluting Coating Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Drug-Eluting Coating Revenue and Growth Rate from 2019-2031
1.4 Market Segmentation
1.4.1 Types of Drug-Eluting Coating
1.4.2 Applications of Drug-Eluting Coating
1.4.3 Research Regions
1.5 Market Dynamics
1.5.1 Drug-Eluting Coating Industry Trends
1.5.2 Drug-Eluting Coating Drivers
1.5.3 Drug-Eluting Coating Market Challenges
1.5.4 Drug-Eluting Coating Market Restraints
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
1.7 Mergers & Acquisitions, Expansion Plans
1.8 Drug-Eluting Coating Industry Development Trends under COVID-19 Outbreak
1.8.1 Global COVID-19 Status Overview
1.8.2 Influence of COVID-19 Outbreak on Drug-Eluting Coating Industry Development

2 Industry Chain Analysis
2.1 Upstream Raw Material Supply and Demand Analysis
2.1.1 Global Drug-Eluting Coating Major Upstream Raw Material and Suppliers
2.1.2 Raw Material Source Analysis
2.2 Major Players of Drug-Eluting Coating
2.2.1 Major Players Manufacturing Base of Drug-Eluting Coating in 2020
2.2.2 Major Players Market Distribution in 2020
2.3 Drug-Eluting Coating Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Drug-Eluting Coating
2.3.3 Labor Cost of Drug-Eluting Coating
2.4 Market Channel Analysis of Drug-Eluting Coating
2.5 Major Down Stream Customers by Application

3 Global Drug-Eluting Coating Market, by Type
3.1 Global Drug-Eluting Coating Revenue and Market Share by Type (2019-2023)
3.2 Global Drug-Eluting Coating Production and Market Share by Type (2019-2023)
3.3 Global Drug-Eluting Coating Revenue and Growth Rate by Type (2019-2023)
3.3.1 Global Drug-Eluting Coating Revenue and Growth Rate of Biocompatible coatings
3.3.2 Global Drug-Eluting Coating Revenue and Growth Rate of Drug-delivery coatings
3.3.3 Global Drug-Eluting Coating Revenue and Growth Rate of Polymer-free coatings/surfaces
3.4 Global Drug-Eluting Coating Price Analysis by Type (2019-2023)
3.4.1 Explanation of Different Type Product Price Trends

4 Drug-Eluting Coating Market, by Application
4.1 Downstream Market Overview
4.2 Global Drug-Eluting Coating Consumption and Market Share by Application (2019-2023)
4.3 Global Drug-Eluting Coating Consumption and Growth Rate by Application (2019-2023)
4.3.1 Global Drug-Eluting Coating Consumption and Growth Rate of Hospital (2019-2023)
4.3.2 Global Drug-Eluting Coating Consumption and Growth Rate of Research institute (2019-2023)

5 Global Drug-Eluting Coating Consumption, Revenue ($) by Region (2019-2023)
5.1 Global Drug-Eluting Coating Revenue and Market Share by Region (2019-2023)
5.2 Global Drug-Eluting Coating Consumption and Market Share by Region (2019-2023)
5.3 Global Drug-Eluting Coating Consumption, Revenue, Price and Gross Margin (2019-2023)
5.4 North America Drug-Eluting Coating Consumption, Revenue, Price and Gross Margin (2019-2023)
5.4.1 North America Drug-Eluting Coating Market Under COVID-19
5.4.2 North America Drug-Eluting Coating SWOT Analysis
5.5 Europe Drug-Eluting Coating Consumption, Revenue, Price and Gross Margin (2019-2023)
5.5.1 Europe Drug-Eluting Coating Market Under COVID-19
5.5.2 Europe Drug-Eluting Coating SWOT Analysis
5.6 China Drug-Eluting Coating Consumption, Revenue, Price and Gross Margin (2019-2023)
5.6.1 China Drug-Eluting Coating Market Under COVID-19
5.6.2 China Drug-Eluting Coating SWOT Analysis
5.7 Japan Drug-Eluting Coating Consumption, Revenue, Price and Gross Margin (2019-2023)
5.7.1 Japan Drug-Eluting Coating Market Under COVID-19
5.7.2 Japan Drug-Eluting Coating SWOT Analysis
5.8 Middle East and Africa Drug-Eluting Coating Consumption, Revenue, Price and Gross Margin (2019-2023)
5.8.1 Middle East and Africa Drug-Eluting Coating Market Under COVID-19
5.8.2 Middle East and Africa Drug-Eluting Coating SWOT Analysis
5.9 India Drug-Eluting Coating Consumption, Revenue, Price and Gross Margin (2019-2023)
5.9.1 India Drug-Eluting Coating Market Under COVID-19
5.9.2 India Drug-Eluting Coating SWOT Analysis
5.10 South America Drug-Eluting Coating Consumption, Revenue, Price and Gross Margin (2019-2023)
5.10.1 South America Drug-Eluting Coating Market Under COVID-19
5.10.2 South America Drug-Eluting Coating SWOT Analysis
5.11 South Korea Drug-Eluting Coating Consumption, Revenue, Price and Gross Margin (2019-2023)
5.11.1 South Korea Drug-Eluting Coating Market Under COVID-19
5.11.2 South Korea Drug-Eluting Coating SWOT Analysis
5.12 Southeast Asia Drug-Eluting Coating Consumption, Revenue, Price and Gross Margin (2019-2023)
5.12.1 Southeast Asia Drug-Eluting Coating Market Under COVID-19
5.12.2 Southeast Asia Drug-Eluting Coating SWOT Analysis

6 Global Drug-Eluting Coating Production by Top Regions (2019-2023)
6.1 Global Drug-Eluting Coating Production by Top Regions (2019-2023)
6.2 North America Drug-Eluting Coating Production and Growth Rate
6.3 Europe Drug-Eluting Coating Production and Growth Rate
6.4 China Drug-Eluting Coating Production and Growth Rate
6.5 Japan Drug-Eluting Coating Production and Growth Rate
6.6 India Drug-Eluting Coating Production and Growth Rate

7 Global Drug-Eluting Coating Consumption by Regions (2019-2023)
7.1 Global Drug-Eluting Coating Consumption by Regions (2019-2023)
7.2 North America Drug-Eluting Coating Consumption and Growth Rate
7.3 Europe Drug-Eluting Coating Consumption and Growth Rate
7.4 China Drug-Eluting Coating Consumption and Growth Rate
7.5 Japan Drug-Eluting Coating Consumption and Growth Rate
7.6 Middle East & Africa Drug-Eluting Coating Consumption and Growth Rate
7.7 India Drug-Eluting Coating Consumption and Growth Rate
7.8 South America Drug-Eluting Coating Consumption and Growth Rate
7.9 South Korea Drug-Eluting Coating Consumption and Growth Rate
7.10 Southeast Asia Drug-Eluting Coating Consumption and Growth Rate

8 Competitive Landscape
8.1 Competitive Profile
8.2 Hemoteq AG (Germany) Market Performance Analysis
8.2.1 Company Profiles
8.2.2 Drug-Eluting Coating Product Profiles, Application and Specification
8.2.3 Hemoteq AG (Germany) Sales, Revenue, Price, Gross Margin 2019-2023
8.2.4 Company Recent Development
8.2.5 Strategies for Company to Deal with the Impact of COVID-19
8.3 N2 Biomedical (US) Market Performance Analysis
8.3.1 Company Profiles
8.3.2 Drug-Eluting Coating Product Profiles, Application and Specification
8.3.3 N2 Biomedical (US) Sales, Revenue, Price, Gross Margin 2019-2023
8.3.4 Company Recent Development
8.3.5 Strategies for Company to Deal with the Impact of COVID-19
8.4 Carmeda AB (Sweden) Market Performance Analysis
8.4.1 Company Profiles
8.4.2 Drug-Eluting Coating Product Profiles, Application and Specification
8.4.3 Carmeda AB (Sweden) Sales, Revenue, Price, Gross Margin 2019-2023
8.4.4 Company Recent Development
8.4.5 Strategies for Company to Deal with the Impact of COVID-19
8.5 Covalon Technologies Ltd. (Canada) Market Performance Analysis
8.5.1 Company Profiles
8.5.2 Drug-Eluting Coating Product Profiles, Application and Specification
8.5.3 Covalon Technologies Ltd. (Canada) Sales, Revenue, Price, Gross Margin 2019-2023
8.5.4 Company Recent Development
8.5.5 Strategies for Company to Deal with the Impact of COVID-19
8.6 AST Products, Inc. (US) Market Performance Analysis
8.6.1 Company Profiles
8.6.2 Drug-Eluting Coating Product Profiles, Application and Specification
8.6.3 AST Products, Inc. (US) Sales, Revenue, Price, Gross Margin 2019-2023
8.6.4 Company Recent Development
8.6.5 Strategies for Company to Deal with the Impact of COVID-19
8.7 Nanocopoeia, Inc. (US) Market Performance Analysis
8.7.1 Company Profiles
8.7.2 Drug-Eluting Coating Product Profiles, Application and Specification
8.7.3 Nanocopoeia, Inc. (US) Sales, Revenue, Price, Gross Margin 2019-2023
8.7.4 Company Recent Development
8.7.5 Strategies for Company to Deal with the Impact of COVID-19
8.8 Armoloy of Connecticut, Inc. (US) Market Performance Analysis
8.8.1 Company Profiles
8.8.2 Drug-Eluting Coating Product Profiles, Application and Specification
8.8.3 Armoloy of Connecticut, Inc. (US) Sales, Revenue, Price, Gross Margin 2019-2023
8.8.4 Company Recent Development
8.8.5 Strategies for Company to Deal with the Impact of COVID-19
8.9 Biophan Technologies, Inc. (US) Market Performance Analysis
8.9.1 Company Profiles
8.9.2 Drug-Eluting Coating Product Profiles, Application and Specification
8.9.3 Biophan Technologies, Inc. (US) Sales, Revenue, Price, Gross Margin 2019-2023
8.9.4 Company Recent Development
8.9.5 Strategies for Company to Deal with the Impact of COVID-19
8.10 Hydromer, Inc. (US) Market Performance Analysis
8.10.1 Company Profiles
8.10.2 Drug-Eluting Coating Product Profiles, Application and Specification
8.10.3 Hydromer, Inc. (US) Sales, Revenue, Price, Gross Margin 2019-2023
8.10.4 Company Recent Development
8.10.5 Strategies for Company to Deal with the Impact of COVID-19
8.11 Biocoat, Inc. (US) Market Performance Analysis
8.11.1 Company Profiles
8.11.2 Drug-Eluting Coating Product Profiles, Application and Specification
8.11.3 Biocoat, Inc. (US) Sales, Revenue, Price, Gross Margin 2019-2023
8.11.4 Company Recent Development
8.11.5 Strategies for Company to Deal with the Impact of COVID-19

9 Global Drug-Eluting Coating Market Analysis and Forecast by Type and Application
9.1 Global Drug-Eluting Coating Market Revenue & Volume Forecast, by Type (2021-2026)
9.1.1 Biocompatible coatings Market Revenue and Volume Forecast (2021-2026)
9.1.2 Drug-delivery coatings Market Revenue and Volume Forecast (2021-2026)
9.1.3 Polymer-free coatings/surfaces Market Revenue and Volume Forecast (2021-2026)
9.2 Global Drug-Eluting Coating Market Revenue & Volume Forecast, by Application (2021-2026)
9.2.1 Hospital Market Revenue and Volume Forecast (2021-2026)
9.2.2 Research institute Market Revenue and Volume Forecast (2021-2026)

10 Drug-Eluting Coating Market Supply and Demand Forecast by Region
10.1 North America Market Supply and Demand Forecast (2021-2026)
10.2 Europe Market Supply and Demand Forecast (2021-2026)
10.3 China Market Supply and Demand Forecast (2021-2026)
10.4 Japan Market Supply and Demand Forecast (2021-2026)
10.5 Middle East and Africa Market Supply and Demand Forecast (2021-2026)
10.6 India Market Supply and Demand Forecast (2021-2026)
10.7 South America Market Supply and Demand Forecast (2021-2026)
10.8 South Korea Market Supply and Demand Forecast (2021-2026)
10.9 Southeast Asia Market Supply and Demand Forecast (2021-2026)
10.10 Explanation of Market Size Trends by Region
10.11 Drug-Eluting Coating Market Trends Analysis

11 New Project Feasibility Analysis
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment

12 Expert Interview Record
13 Research Finding and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Data Source
 

Search results for Chemical & Materials Industry